top of page
HOME
ABOUT US
Management Team
Scientific Advisory Board
NEWS
SCIENCE
PIPELINE
CUSHING'S SYNDROME
PSC
MULTIPLE MYELOMA
PARTNERSHIPS
CONTACT
Press Releases
Date
News Release
05/31/2022
SteroTherapeutics Granted Orphan Drug Designation to ST-003, a Novel Drug Candidate for the Treatment of Primary Sclerosing Cholangitis
03/30/2022
SteroTherapeutics Signs Licensing Agreement Aimed to Improve the Treatment of Multiple Myeloma
12/02/2020
SteroTherapeutics, LLC signs CRADA Agreement with NIH to Develop a Novel Treatment for Cushing Syndrome Patients
03/28/2019
SteroTherapeutics Receives New U.S. Patent for treatment of non-alcoholic Steatohepatitis (NASH)
04/04/2018
SteroTherapeutics Receives FDA Orphan-Drug Designation
02/27/2018
SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)
For Investor and Media Inquiries Please Contact:
Lisa Sher
lsher@sterotx.com
(970) 987-2654
bottom of page